|
FDA Issues Enforcement Action Based on Non-FDA Inspection
PHILADELPHIA — International cooperation between regulators is “taking off” — a trend that could limit the amount of duplicate inspections drugmakers face, a top CDER official says.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives